Literature DB >> 19059206

Fibrinogen has chaperone-like activity.

Huadong Tang1, Yan Fu, Yujie Cui, Yingbo He, Xing Zeng, Victoria A Ploplis, Francis J Castellino, Yongzhang Luo.   

Abstract

Partially or completely unfolded polypeptides are highly prone to aggregation due to nonspecific interactions between their exposed hydrophobic surfaces. Extracellular proteins are continuously subjected to stresses conditions, but the existence of extracellular chaperones remains largely unexplored. The results presented here demonstrate that one of the most abundant extracellular proteins, fibrinogen has chaperone-like activity. Fibrinogen can specifically bind to nonnative form of citrate synthase and inhibit its thermal aggregation and inactivation in an ATP-independent manner. Interestingly, fibrinogen maintains thermal-denatured luciferase in a refolding competent state allowing luciferase to be refolded in cooperation with rabbit reticulocyte lysate. Fibrinogen also inhibits fibril formation of yeast prion protein Sup35 (NM). Furthermore, fibrinogen rescues thermal-induced protein aggregation in the plasma of fibrinogen-deficient mice. Our studies demonstrate the chaperone-like activity of fibrinogen, which not only provides new insights into the extracellular chaperone protein system, but also suggests potential diagnostic and therapeutic approaches to fibrinogen-related pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19059206      PMCID: PMC2663026          DOI: 10.1016/j.bbrc.2008.11.112

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  41 in total

1.  Binding of disease-associated prion protein to plasminogen.

Authors:  M B Fischer; C Roeckl; P Parizek; H P Schwarz; A Aguzzi
Journal:  Nature       Date:  2000-11-23       Impact factor: 49.962

Review 2.  Folding of newly translated proteins in vivo: the role of molecular chaperones.

Authors:  J Frydman
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

Review 3.  Protein aggregation in disease: a role for folding intermediates forming specific multimeric interactions.

Authors:  Arthur Horwich
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

4.  Increased fibrinogen production in type 2 diabetic patients without detectable vascular complications: correlation with plasma glucagon concentrations.

Authors:  R Barazzoni; M Zanetti; G Davanzo; E Kiwanuka; P Carraro; A Tiengo; P Tessari
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

5.  Tissue-type plasminogen activator is a multiligand cross-beta structure receptor.

Authors:  Onno Kranenburg; Barend Bouma; Loes M J Kroon-Batenburg; Arie Reijerkerk; Ya-Ping Wu; Emile E Voest; Martijn F B G Gebbink
Journal:  Curr Biol       Date:  2002-10-29       Impact factor: 10.834

6.  A total fibrinogen deficiency is compatible with the development of pulmonary fibrosis in mice.

Authors:  V A Ploplis; J Wilberding; L McLennan; Z Liang; I Cornelissen; M E DeFord; E D Rosen; F J Castellino
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

7.  Molecular chaperone properties of serum amyloid P component.

Authors:  A R Coker; A Purvis; D Baker; M B Pepys; S P Wood
Journal:  FEBS Lett       Date:  2000-05-12       Impact factor: 4.124

Review 8.  Atherosclerosis: another protein misfolding disease?

Authors:  Fulvio Ursini; Kelvin J A Davies; Matilde Maiorino; Tiziana Parasassi; Alex Sevanian
Journal:  Trends Mol Med       Date:  2002-08       Impact factor: 11.951

9.  Characteristics of adults with and without cystic fibrosis-related diabetes.

Authors:  A I Adler; E Gunn; C S Haworth; D Bilton
Journal:  Diabet Med       Date:  2007-10       Impact factor: 4.359

10.  Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases.

Authors:  Monica Bucciantini; Elisa Giannoni; Fabrizio Chiti; Fabiana Baroni; Lucia Formigli; Jesús Zurdo; Niccolò Taddei; Giampietro Ramponi; Christopher M Dobson; Massimo Stefani
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

View more
  7 in total

1.  Two novel fibrinogen variants in the C-terminus of the Bβ-chain: fibrinogen Rokycany and fibrinogen Znojmo.

Authors:  Roman Kotlín; Zuzana Reicheltová; Jirí Suttnar; Peter Salaj; Ingrid Hrachovinová; Tomás Riedel; Martin Malý; Milan Oravec; Jan Kvasnicka; Jan Evangelista Dyr
Journal:  J Thromb Thrombolysis       Date:  2010-10       Impact factor: 2.300

2.  Citrate synthase is a novel in vivo matrix metalloproteinase-9 substrate that regulates mitochondrial function in the postmyocardial infarction left ventricle.

Authors:  Lisandra E de Castro Brás; Courtney A Cates; Kristine Y DeLeon-Pennell; Yonggang Ma; Rugmani Padmanabhan Iyer; Ganesh V Halade; Andriy Yabluchanskiy; Gregg B Fields; Susan T Weintraub; Merry L Lindsey
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

3.  Characterization of Plasma SDS-Protein Aggregation Profile of Patients with Heart Failure with Preserved Ejection Fraction.

Authors:  Marisol Gouveia; Cristine Schmidt; Manuel Teixeira; Mário Lopes; Susana S Aveiro; Pedro Domingues; Ke Xia; Wilfredo Colón; Rui Vitorino; Rita Ferreira; Mário Santos; Sandra Vieira; Fernando Ribeiro
Journal:  J Cardiovasc Transl Res       Date:  2022-10-21       Impact factor: 3.216

4.  Multistep growth of amyloid intermediates and its inhibition toward exploring therapeutic way: A case study using insulin B chain and fibrinogen.

Authors:  Naoki Yamamoto; Eri Chatani
Journal:  Biophys Physicobiol       Date:  2022-05-10

5.  Fibrinogen facilitates the anti-tumor effect of nonnative endostatin.

Authors:  Huadong Tang; Yan Fu; Qingxin Lei; Qing Han; Victoria A Ploplis; Francis J Castellino; Ling Li; Yongzhang Luo
Journal:  Biochem Biophys Res Commun       Date:  2009-01-22       Impact factor: 3.575

6.  Beyond genetic factors in familial amyloidotic polyneuropathy: protein glycation and the loss of fibrinogen's chaperone activity.

Authors:  Gonçalo da Costa; Ricardo A Gomes; Ana Guerreiro; Élia Mateus; Estela Monteiro; Eduardo Barroso; Ana V Coelho; Ana Ponces Freire; Carlos Cordeiro
Journal:  PLoS One       Date:  2011-10-28       Impact factor: 3.240

7.  Transthyretin Amyloidosis: Chaperone Concentration Changes and Increased Proteolysis in the Pathway to Disease.

Authors:  Gonçalo da Costa; Cristina Ribeiro-Silva; Raquel Ribeiro; Samuel Gilberto; Ricardo A Gomes; António Ferreira; Élia Mateus; Eduardo Barroso; Ana V Coelho; Ana Ponces Freire; Carlos Cordeiro
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.